Updated:
Xingtai Capital
Xingtai Capital is a private equity based in Hong Kong, founded 2014; the Altss profile covers its classification, headquarters, registration, AUM band, and...
Xingtai Capital
Xingtai Capital is an SEC-registered investment adviser in HONG KONG, registered since 2020. It operates under SEC guidelines.
General information
Firm type
Private Equity
Year founded
2014
Location
Region
Asia
Country
China
City
Hong Kong
Corporate office
Hefei, China
Additional offices
Shanghai, China · Hong Kong
Principals
Michelle Leung
Founding Partner and Chief Executive Officer
Bingchao Cao
Partner and Chief Investment Officer
Sector focus
Frequently asked questions
Who runs investment decisions at Xingtai Capital?
Bingchao Cao serves as Partner and Chief Investment Officer, leading the investment team. His prior experience includes portfolio management at Lombard Odier for a Greater China-focused portfolio, and senior analyst roles at Citadel and SAC Capital Advisors on fundamental equity long/short teams. CEO Michelle Leung leads the executive team and brings private equity and operating experience, but the website indicates Cao directs the investment process.
How does Xingtai Capital source investment opportunities?
The firm conducts local, on-the-ground investment research from its Shanghai office, paired with institutional infrastructure through its Hong Kong SFC-licensed entity. The team's background — combining local consumer private equity experience from Lunar Capital and long/short hedge fund research from Citadel and Lombard Odier — suggests sourcing relies on fundamental, bottom-up analysis rather than auction processes or intermediary-driven deal flow.
Is Xingtai Capital structured as a private equity firm or a hedge fund?
Xingtai positions itself as a value-driven investor in Chinese growth running a long-only equity strategy, not a traditional private equity fund with control positions. Its Hong Kong entity holds a Type 9 asset management license from the SFC, consistent with a fund management structure. The firm's listed strategies include venture capital, early-stage, expansion/late-stage, and fund of funds, creating a hybrid posture that extends beyond a single fund format.
Does Xingtai Capital participate in fund commitments or only direct deals?
According to the strategy listing, Xingtai covers both direct investments across early-stage to late-stage companies and fund of funds allocations. The website does not disclose the split between direct and fund commitments, nor any named underlying fund relationships. This dual approach is unusual among smaller China-focused managers and suggests a portfolio construction philosophy that blends direct exposure with manager selection.
What investment stages does Xingtai Capital target?
The firm targets early-stage seed and start-up rounds through to expansion and late-stage growth, alongside venture capital and fund of funds allocations. This broad stage mandate, combined with the team's public-market background at Citadel and Lombard Odier, suggests a strategy that may cross over between private and public Chinese growth companies, though the website does not specify public-market holdings.
Where does Xingtai Capital's team experience come from?
CEO Michelle Leung previously served as a Partner at Lunar Capital, a Chinese consumer private equity fund, and as COO of TOM Group, a Hutchison Whampoa associate. She also worked in investment banking at Goldman Sachs in Hong Kong and New York. CIO Bingchao Cao managed a Greater China portfolio at Lombard Odier, and worked as a senior analyst at Citadel and SAC Capital Advisors. Both hold degrees from Harvard Business School and Tsinghua University/Dartmouth College respectively.
What is Xingtai Capital's regulatory posture?
Xingtai Capital Management Limited is licensed by the Hong Kong Securities and Futures Commission to conduct Type 9 (asset management) regulated activity under CE number BBU259. The Shanghai office conducts investment research, but the regulated entity and client-facing operations are anchored in Hong Kong. This subjects the firm to Hong Kong's regulatory framework rather than mainland China's asset management rules.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: